Glycorex Transplantation Valuation Multiples

Glycorex Transplantation Overview

About Glycorex Transplantation

Glycorex Transplantation AB is a medical technology company with expertise in biologically active carbohydrates and extracorporeal blood treatments. The company has developed antigen-specific immunoadsorption and a molecular-level nanosurgical technology that removes antibodies from the blood. Its focus areas include transplantation, blood transfusion, and autoimmune diseases. The company's products include Glycosorb ABO and Glycosorb ABO 4 ml, which reduce anti-A/B antibodies and enable organ transplants across the blood group barrier and the production of universal blood components. Sales are conducted through the company's own channels and distributors in selected markets, with sales across more than 30 countries, and Europe is the highest market.

Founded

1996

HQ

Employees

20

Website

glycorex.se

Sectors

Diagnostics & GenomicsBioTech

Financials (FY)

Revenue: $4M

EBITDA: $214K

EV

$10M

Valuation Multiples

Multiples.vc

Start free trial

Glycorex Transplantation Financials

Glycorex Transplantation reported last fiscal year revenue of $4M and EBITDA of $214K.

In the same fiscal year, Glycorex Transplantation generated $4M in gross profit, $214K in EBITDA, and had net loss of ($840K).

Glycorex Transplantation P&L

In the most recent fiscal year, Glycorex Transplantation reported revenue of $4M and EBITDA of $214K.

Glycorex Transplantation expects next 12-month revenue of XXX and NTM EBITDA of XXX

Glycorex Transplantation Stock Performance

Glycorex Transplantation has current market cap of $11M, and enterprise value of $10M.

Glycorex Transplantation's stock price is $0.13.

Glycorex Transplantation Valuation Multiples

Glycorex Transplantation trades at 2.4x EV/Revenue multiple, and 47.1x EV/EBITDA.

Glycorex Transplantation Financial Valuation Multiples

As of April 18, 2026, Glycorex Transplantation has market cap of $11M and EV of $10M.

Equity research analysts estimate Glycorex Transplantation's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Glycorex Transplantation has a P/E ratio of (12.6x).

Glycorex Transplantation Margins & Growth Rates

Glycorex Transplantation's revenue in the last fiscal year grew by 10%.

Glycorex Transplantation's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.

Glycorex Transplantation Public Comps

See public comps and valuation multiples for other Diagnostics & Genomics comps.

Glycorex Transplantation M&A Activity

Glycorex Transplantation acquired XXX companies to date.

Last acquisition by Glycorex Transplantation was on XXXXXXXX, XXXXX. Glycorex Transplantation acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Glycorex Transplantation Investment Activity

Glycorex Transplantation invested in XXX companies to date.

Glycorex Transplantation made its latest investment on XXXXXXXX, XXXXX. Glycorex Transplantation invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).